Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)

Sponsor
University Hospital, Limoges (Other)
Overall Status
Recruiting
CT.gov ID
NCT06093724
Collaborator
(none)
50
1
1
33.8
1.5

Study Details

Study Description

Brief Summary

The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Static and dynamic perineo-pelvic MRI
N/A

Detailed Description

Transgender people are estimated to be about 0,3 to 1 % of general population, and MtF reassignment surgery is raising. Vaginoplasty is not always necessary, but is usually an important step into gender transition. In France, surgical techniques' gold-standard is the peno-scrotal inversion vaginoplasty, which consists in the creation of a neo-vagina with peno-scrotal skin graft. Genital, perineum and pelvic anatomy is modified, without knowing in advance about functional and aesthetic results. MRI is the best way to assess soft tissue anatomy in the pelvis. Though, only few studies have assessed pre and post-operative imaging in patients undergoing vaginoplasty, and none have been prospective, neither have assessed the risk of rectocele. The issue is legitimate, because the surgery weakens elements of pelvic fixity, and fixity issues can appear secondarily.

MtF transgender patients operated for a vaginoplasty are undergoing static and dynamic MRI before the surgery, at 6 and at 24 post-operative months. We look after the appearance of a rectocele and it's evolution in time, as criteria for the assessment of pelvic fixity.

Follow-up is composed of several consultations including post-operative MRI, but also clinical measures, census of post-operative issues, and questionnaires for the assessment of secondary objectives.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)
Actual Study Start Date :
Aug 21, 2023
Anticipated Primary Completion Date :
Aug 21, 2024
Anticipated Study Completion Date :
Jun 15, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anatomy reorganization after vaginoplasty in transgender women (MtF)

The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.

Diagnostic Test: Static and dynamic perineo-pelvic MRI
Static and dynamic perineo-pelvic MRI before surgery, and at 6 and 24 months after surgery.

Outcome Measures

Primary Outcome Measures

  1. Measurement comparison of the rectal bulge's size and classification [6 months and 24 months]

    Comparison and classification by pre-operative and post-operative MRI

Secondary Outcome Measures

  1. Rectocele [6 months and 24 months]

    Describe the rectocele's mean size and it's progress

  2. Rectocele [6 months and 24 months]

    Describe the rectocele size's progress by class

  3. Reproducibility in the rectocele's measurement [6 months and 24 months]

    Evaluate intra and inter-operator reproducibility in the rectocele's measurement

  4. Symptomatology pelvic fixity [6 months and 24 months]

    Evaluate correlation between symptomatology and the rectocele assessment

  5. Factors pelvic fixity [6 months and 24 months]

    Evaluate correlation between factors and the rectocele assessment

  6. Skin-graft's neo-vagina's sizes [6 months and 24 months]

    Evaluate correlation between the skin-graft's size in cm² and the neo-vagina's sizes (lenght, width) in cm

  7. Imaging measures [6 months and 24 months]

    Evaluate modifications of imaging measures size in cm² and the neo-vagina's sizes (lenght, width) in cm

  8. Urinary quality [6 months and 24 months]

    Evaluate evolution of unrinary quality of life with Urinary Symptom Profile (USP) score, from 0 (best) to 39 (worst)

  9. Self-imaging [6 months and 24 months]

    Evaluate evolution of self-imaging with Body Image (BI-1) score, from 30 (no change) to 150 (change) ; and Female Genital Self-Image Scale (FGSIS) score, from 7 (worst) to 28 (best)

  10. Sexual quality [6 months and 24 months]

    Evaluate evolution of sexual quality of life with Operated Male-to-Female Sexual Function Index (OmtFSFI) score, from 18 (best) to 72 (worst)

  11. Post-operative issues [Instantly, 6 months and 24 months]

    Epidemiologic census of post-operative issues

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient over 18 years old

  • Patient admitted in urology ward at Limoges' University Hospital for MtF sexual reassignment surgery by vaginoplasty

  • Patient affiliated or benefitting from a social security system

  • Patient free, informed, written and signed consent

Exclusion Criteria:
  • Patient admitted for vulvoplasty surgery

  • Patient admitted for second vaginoplasty surgical gesture

  • Contraindication of realizing an MRI

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital, Limoges Limoges France 87042

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT06093724
Other Study ID Numbers:
  • 87RI23_005-TRANSPELV
First Posted:
Oct 23, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Limoges

Study Results

No Results Posted as of Oct 23, 2023